153 - HIV Updates for the Non-HIV Specialist: Principles, Pearls and Pitfalls

Friday, October 18, 2024

1:45 PM – 3:00 PM US PT

Location: 408 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Valeria Cantos, MD

Associate Professor
Division of Infectious Diseases
Emory University
Atlanta, GA, United States
Matthew Hickey, MD, MAS (he/him/his)

Assistant Professor
Division of HIV, Infectious Diseases & Global Medicine, San Francisco General Hospital, University of California, San Francisco
San Francisco, CA, United States
Vivek Jain, MD, MAS (he/him/his)

Professor of Medicine
Division of HIV, Infectious Diseases & Global Medicine, San Francisco General Hospital, University of California, San Francisco
San Francisco, CA, United States

Faculty(s)

Eric Daar, MD

Chief, Division of HIV Medicine
Medicine
Lundquist Institute at Harbor-UCLA Medical Center
Torrance, CA, United States
Melanie Thompson, MD (she/her/hers)

Past Principal Investigator
AIDS Research Consortium of Atlanta
Atlanta, GA, United States
Alicia Pineirua, ID specialist, Master in Public Health (she/her/hers)

President of the Secretariat
CISIDAT, Mexico

Disclosure(s):

Valeria D. Cantos, MD: Gilead Sciences: Grant/Research Support (Ongoing)

Matthew D. Hickey, MD, MAS: No financial relationships to disclose

Vivek Jain, MD, MAS: Shionogi: Advisor/Consultant (Terminated, April 30, 2022)

Eric S. Daar, MD: Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Theratechnologies: Advisor/Consultant (Ongoing); ViiV: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Melanie A. Thompson, MD: Excision Biotherapeutics: Chair, IDMC (Ongoing)

Alicia Pineirua, ID specialist, Master in Public Health: Gilead Sciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); ViiV Healthcare/GSK: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

analyze the latest antiretroviral treatment options for people with hiv;
describe the latest guidance for managing the primary care of people with hiv;
recognize current approaches to managing opportunistic infections in people with hiv.

Presentations:

1:45 PM – 2:10 PM US PT

Cutting Edge ART in 2024
Speaker: Eric S. Daar, MD – Lundquist Institute at Harbor-UCLA Medical Center
2:10 PM – 2:35 PM US PT

HIV Primary Care: Modern Challenges and Guideline Update
Speaker: Melanie A. Thompson, MD (she/her/hers) – AIDS Research Consortium of Atlanta
2:35 PM – 3:00 PM US PT

Opportunistic Infection Management: New Aspects to an Old Foe
Speaker: Alicia Pineirua, ID specialist, Master in Public Health (she/her/hers) – CISIDAT